3 Increasing evidence, particularly from SPRINT, suggests the feasibility and benefits of intensive BP control goals well below < 140/90. 2 In contrast, JNC 8 relaxed treatment targets to < 150 in most older patients (age ≥ 60) and SBP < 140 for all others. JNC 7 targeted systolic blood pressure (SBP) < 140 mmHg for most and < 130 in higher risk patients. The standards for evaluating BP control have shifted over the past decade. Treatment efforts need to be monitored because of their impact on public health. Despite these benefits, the detection, treatment, and control of hypertension remain suboptimal. 1 Treatment to reduce blood pressure (BP) reduces the risk of CVD, stroke, heart failure, chronic kidney disease, and all-cause mortality. Hypertension affects over 100 million individuals in the USA and is a major risk factor for cardiovascular disease (CVD).
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |